Omega Healthcare Investors Inc financial data

Symbol
OHI on NYSE
Location
303 International Circle,, Suite 200, Hunt Valley, MD
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 1, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 111 % -24.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 295M shares +14.4%
Common Stock, Shares, Outstanding 293M shares +15.4%
Entity Public Float 8.7B USD +17.6%
Common Stock, Value, Issued 29.3M USD +15.4%
Weighted Average Number of Shares Outstanding, Basic 291M shares +16.8%
Weighted Average Number of Shares Outstanding, Diluted 303M shares +15.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.11B USD +14%
General and Administrative Expense 100M USD +21.5%
Income Tax Expense (Benefit) 14.4M USD +37.7%
Net Income (Loss) Attributable to Parent 137M USD +20%
Earnings Per Share, Basic 1 USD/shares +22.4%
Earnings Per Share, Diluted 1 USD/shares +22.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 734M USD +1986%
Operating Lease, Right-of-Use Asset 28.3M USD -6.22%
Goodwill 645M USD +0.17%
Assets 10.5B USD +19.2%
Liabilities 5.36B USD +8.28%
Accumulated Other Comprehensive Income (Loss), Net of Tax 96.8M USD +182%
Retained Earnings (Accumulated Deficit) 4.33B USD +12.2%
Stockholders' Equity Attributable to Parent 4.99B USD +34.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.19B USD +33%
Liabilities and Equity 10.5B USD +19.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 182M USD +20.1%
Net Cash Provided by (Used in) Financing Activities -348M USD -86.9%
Net Cash Provided by (Used in) Investing Activities 19.3M USD
Common Stock, Shares Authorized 700M shares +100%
Common Stock, Shares, Issued 293M shares +15.4%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -145M USD -77.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 773M USD +1874%
Interest Paid, Excluding Capitalized Interest, Operating Activities 63.1M USD +7.94%
Deferred Tax Assets, Valuation Allowance 1.93M USD -4.89%
Operating Lease, Liability 30.3M USD -4.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 533M USD +66.3%
Deferred Tax Assets, Operating Loss Carryforwards 2.05M USD -1.49%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 14.5M USD +37.1%
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 8.43B USD +21.3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 316M USD +3.6%
Share-based Payment Arrangement, Expense 43.3M USD +20.5%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%